Finepoint Capital »

Calidi Biotherapeutics shares owned by Finepoint Capital

Quarter-by-quarter ownership of Calidi Biotherapeutics shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6k 1.0k 1.52

More positions owned by Finepoint Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Qxo Com New (QXO)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Rxo Common Stock (RXO)
Solid Biosciences Com New (SLDB)
Aleanna Com Cl A (ANNA)
Aleanna *w Exp 12/13/202 (ANNAW)
MoneyHero *w Exp 09/13/202 (MNYWW)
Calidi Biotherapeutics Com New

View all positions for Finepoint Capital

Top funds holding Calidi Biotherapeutics

HighTower Advisors
Vanguard Group
Geode Capital Management
Belpointe Asset Management
Warberg Asset Management
Rs Crum
UBS Group
Highbridge Capital Management
Finepoint Capital
Apollo Management Holdings
Royal Bank of Canada
Barrett & Company
Advisor Group Holdings
FMR
Tradewinds Capital Management

View all funds holding Calidi Biotherapeutics